Jeffrey Sicat
Endocrinology, Diabetes & Metabolism · Glen Allen, VANPI 1407883689
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $572,397 of the $656,625 with a category attached, or 87.2%. Novo Nordisk accounts for 70.2% of it on its own, with 11 other manufacturers making up the rest. Among endocrinology, diabetes & metabolism clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 919 payments — averaging $714.50 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$461K
- Lilly USA, LLC$183K
- Boehringer Ingelheim$13K
- Currax Pharmaceuticals LLC$137
- Abbott$105
- Vivus LLC$86
- plus $149 from 6 others
What the payments were for
- Consulting fees$8,1951%
- Speaking & faculty fees$572,39787%
- Travel & lodging$58,9229%
- Food & beverage$16,9613%
- Education$1490%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 478 | $460,837 |
| Lilly USA, LLC | 385 | $182,668 |
| Boehringer Ingelheim | 27 | $12,644 |
| Currax Pharmaceuticals LLC | 10 | $137 |
| Abbott | 5 | $105 |
| Vivus LLC | 2 | $86 |
| Eisai Inc. | 3 | $46 |
| Dexcom, Inc. | 2 | $37 |
| Nalpropion Pharmaceuticals LLC | 1 | $20 |
| Amgen | 1 | $18 |
| Endo Pharmaceuticals Inc. | 1 | $15 |
| Kvk-tech, Inc. | 4 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$656,625 in reported general payments places this provider in the 95th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
See all endocrinology, diabetes & metabolism providers in Virginia →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 145 | $181,172 |
| OzempicSemaglutide | 98 | $151,011 |
| JardianceEmpagliflozin | 76 | $67,929 |
| WegovySemaglutide | 16 | $21,996 |
| FarxigaDapagliflozin Propanediol | 12 | $18,862 |
| Bupropion XlBupropion Hcl | 72 | $1,916 |
| SynthroidLevothyroxine Sodium | 13 | $1,286 |
| Metformin Hcl ErMetformin Hcl | 122 | $1,242 |
| Topiramate | 85 | $638 |
| Levothyroxine Sodium | 25 | $425 |
| Naltrexone Hcl | 17 | $337 |
| Ondansetron OdtOndansetron | 19 | $237 |
| Rosuvastatin Calcium | 19 | $202 |
| Metformin Hcl | 20 | $146 |
| Atorvastatin Calcium | 28 | $139 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $182,668 | $181,172145 claims |
| Novo NordiskOzempic, Wegovy | $460,837 | $173,007114 claims |
| Boehringer IngelheimJardiance | $12,644 | $67,92976 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 223 endocrinology, diabetes & metabolism providers in Virginia.
Other endocrinology, diabetes & metabolism in Glen Allen
- Farhad ZangenehSterling$1.2M
- James MulindaRoanoke$788K
- Dewey BaileyRoanoke$645K
- Domenica RubinoArlington$608K
- Samamtha HudsonMidlothian$372K
- Elias SirajNorfolk$316K
- Allen BurrisPowhatan$261K
- Samim EnayatFairfax$217K
- Denise ArmelliniFairfax$152K
- Ben PhillipsMidlothian$99K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.